Boston Family Office’s GSK GSK Stock Holding History

Boston Family Office’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,225	Closed	-$230K	–	266
2022 Q2	$230K	Hold	4,225	–	–	0.02%	254
2022 Q1	$230K	Hold	4,225	–	–	0.02%	270
2021 Q4	$233K	Hold	4,225	–	–	0.02%	266
2021 Q3	$202K	Hold	4,225	–	–	0.01%	276
2021 Q2	$210K	Sell	4,225 -280	-6%	-$13.9K	0.02%	268
2021 Q1	$237K	Sell	4,505 -1,678	-27%	-$88.3K	0.02%	249
2020 Q4	$284K	Sell	6,183 -1,431	-19%	-$65.7K	0.02%	238
2020 Q3	$358K	Sell	7,614 -208	-3%	-$9.78K	0.03%	204
2020 Q2	$399K	Hold	7,822	–	–	0.04%	191
2020 Q1	$370K	Sell	7,822 -262	-3%	-$12.4K	0.04%	187
2019 Q4	$475K	Sell	8,084 -240	-3%	-$14.1K	0.05%	191
2019 Q3	$444K	Buy	8,324 +240	+3%	+$12.8K	0.05%	195
2019 Q2	$404K	Hold	8,084	–	–	0.04%	209
2019 Q1	$422K	Buy	8,084 +1,058	+15%	+$55.2K	0.05%	202
2018 Q4	$336K	Buy	7,026 +1,315	+23%	+$62.9K	0.04%	214
2018 Q3	$287K	Hold	5,711	–	–	0.03%	236
2018 Q2	$288K	Hold	5,711	–	–	0.03%	231
2018 Q1	$279K	Hold	5,711	–	–	0.03%	233
2017 Q4	$253K	Sell	5,711 -172	-3%	-$7.62K	0.03%	237
2017 Q3	$299K	Hold	5,883	–	–	0.03%	231
2017 Q2	$317K	Hold	5,883	–	–	0.04%	220
2017 Q1	$310K	Sell	5,883 -476	-7%	-$25.1K	0.04%	215
2016 Q4	$306K	Hold	6,359	–	–	0.04%	215
2016 Q3	$343K	Hold	6,359	–	–	0.04%	207
2016 Q2	$345K	Hold	6,359	–	–	0.04%	208
2016 Q1	$322K	Sell	6,359 -4,133	-39%	-$209K	0.04%	207
2015 Q4	$529K	Hold	10,492	–	–	0.07%	171
2015 Q3	$504K	Hold	10,492	–	–	0.07%	179
2015 Q2	$546K	Sell	10,492 -1,196	-10%	-$62.2K	0.07%	190
2015 Q1	$674K	Sell	11,688 -480	-4%	-$27.7K	0.08%	177
2014 Q4	$650K	Sell	12,168 -416	-3%	-$22.2K	0.08%	181
2014 Q3	$723K	Buy	12,584 +80	+0.6%	+$4.6K	0.09%	170
2014 Q2	$836K	Sell	12,504 -300	-2%	-$20.1K	0.11%	163
2014 Q1	$855K	Hold	12,804	–	–	0.11%	161
2013 Q4	$855K	Hold	12,804	–	–	0.11%	160
2013 Q3	$803K	Buy	12,804 +400	+3%	+$25.1K	0.11%	158
2013 Q2	$775K	Buy	+12,404	New	+$775K	0.12%	155